• Nick Kotov's work on dental enamel published in Nature

    Kotov Lab develops structural batteries for mobile robots

    These biomorphic batteries could provide more energy to robots.

  • Akadeum Life Sciences

    Call for Nominations for third round of BI Innovator Awards - Due March 31, 2021

    The goal of the Innovator Award is to recognize faculty, graduate student and postdoctoral researchers.

  • Single Cell Technologies

    Capturing natural killer cells and harvesting their exosomes to fight cancer

    A new microfluidic chip from S. Nagrath's lab enables investigation of the potential for exosomes to combat cancer cells.

  • BI Startup EVOQ Therapeutics inks license and collaboration agreement with Amgen

    Under this agreement EVOQ and Amgen will work on discovery and development of drugs for autoimmune disorders.

  • BI Challenge leads to new interdisciplinary collaboration to target glioblastomas.

    Joerg Lahann and Maria Castro are collaborating on synthetic nanoparticles for brain delivery to target glioblastoma.

  • Kotov and VanEpps collaborate to create new class of antibiotics

    FDA awards $5M to establish Center for Research on Complex Generics

    Anna Schwendeman will co-direct the Center with James Polli from the University of Maryland

  • Elegus

    Three new startup companies launched in FY20 based on BI Technologies

    Three startup companies were launched based on research from BI research labs in FY20.

  • BI Research Response and Resources for COVID-19

    BI researchers are using their expertise to combat COVID-19 on multiple fronts.

  • Science article from the Kotov Lab reports on complex nanoparticle assemblies.

    Find out more about these particles and their properties.

  • Biointerfaces Background 05

    Resources for COVID-19

    A list of resources to keep up to date on COVID-19 at UM

  • Single Cell Technologies

    New startup company, Labyrinth Biotech, licenses liquid biopsy technology

    Labyrinth Biotech is the 8th startup launched at BI and is based on technology developed in Sunitha Nagrath's lab.

  • Three-dimensional (3D) adipose tissue organoids for disease modeling. Lipid (red), actin (green), nucleus (blue).

    BI teams receive Biosciences Initiative awards for high-impact research

    3 major research initiatives projects were awarded to BI faculty in the latest round of funding from the Biosciences Initiative

  • Implanted scaffolds could offer early cancer detection

    The Shea Lab reports on their recent findings on implantable scaffolds that could aid in early cancer detection and diagnosis

  • Van Epps elected Fellow of the American College of Emergency Physicians

    Scott VanEpps Named Taubman Emerging Scholar

    The Taubman Emerging Scholars Program supports early-career clinician-scientists who are on the UM Medical School faculty.

  • Nature Materials publication from the Kotov lab reports on Kirigami modulators

    Kirigami inspired devices enable Terahertz circular dichroism spectroscopy of biomaterials

  • New Science article on ice-proofing coatings developed by the Tuteja lab

    Anish Tuteja and collaborator Michael Thouless publish their findings on developing ice-proofing coatings for large structures

  • Biopsy alternative: A wearable device that captures cancer cells from blood

    The device can continuously collect cancer cells from the bloodstream and was developed by S. Nagrath and D. Hayes

  • A barrier-free environment for ongoing collaboration

    We provide a state of the art collaboratory.

  • Creating a new research paradigm Delivering transformative technologies

    We foster collaborative, interdisciplinary, and groundbreaking research through collocation in a dynamic research environment.

  • Solving the biggest, most complex health challenges of our time

    Making interdisciplinary collaborations happen is our mission.

Charting a new generation of biomedical research

The breakthrough biomedical discoveries of the future — discoveries with the power to transform healthcare and change millions of lives — will not take place in disciplinary silos or isolated labs. They will occur at the interface of disciplines, and they will be fueled by innovative, forward-thinking, and often unexpected collaborations among leading investigators from life and physical sciences.

Making those collaborations happen is the mission of the University of Michigan Biointerfaces Institute. It’s a mission we achieve every day, a vision that becomes reality through a combination of superb talent, peerless facilities, non-stop networking, and funding opportunities that ignite new discoveries and speed the delivery of high-impact healthcare to the world.

BI Research

Research within the institute focuses on the juncture between physical and biological systems and comprises of five research clusters that break down disciplinary barriers to generate high-impact biomedical innovations.

Single Cell Technologies

Single Cell Technologies

To build a synergistic scientific and technological platform to understand a single cell through the convergence of biology, computation and engineering.

Learn More
Cell and Tissue Engineering

Cell and Tissue Engineering

To understand fundamental principles of cell biology and exploit this knowledge to develop novel technologies for manipulating biological materials.

Learn More
Neural Engineering

Neural Engineering

To develop methods to probe the nervous system and to generate novel neural interfaces.

Learn More


To probe nanomaterials self-assembly through simulation and guide the development of new nanomaterials.

Learn More
Advanced Materials and Drug Delivery

Advanced Materials and Drug Delivery

To create and apply cutting-edge biomaterials for high-impact biomedical applications and to create paradigm-changing approaches and systems for advanced drug delivery.

Learn More

BI Impact

BI researchers are active contributors to the university’s research mission: engaging in scientific discovery and entrepreneurship across the institute and the entire campus.  At BI, we are making scholarly impact and technological strides, while training the next generation of biomedical engineers.

Research Accomplishments


in research expenditures since 2012


Distribution In Seed Funding To 25+ Multi-Disciplinary Teams


Department Challenges Organized That Brought Together 350+ Participants

Since 2012 BI Researchers Have Participated In

1700+ Publications
120,000+ Citations


Issued Patents

New Startups

Events & Announcements

The Biointerfaces Institute brings extensive experience to the collaborations that lead to scientific breakthroughs, successful translation, and advanced learning.

Work With Us